212332-40-6
- Name: 3-Bromo-5-isopropoxypyridine
- Chemical Name: 3-bromo-5-propan-2-yloxypyridine
- CAS Number: 212332-40-6
- Molecular Formula: C8H10BrNO
- Molecular Weight: 216.075
- Create Date: 2018-07-23 18:19:04
- Modify Date: 2024-01-10 13:36:10
| Name | 3-bromo-5-propan-2-yloxypyridine |
|---|---|
| Synonyms |
QC-1410
3-bromo-5-isopropoxy-pyridine 3-bromo-5-(1-methylethoxy)pyridine 5-bromo-3-isopropoxypyridine Pyridine, 3-bromo-5-(1-methylethoxy)- 3-bromo-5-[(1-methylethyl)oxy]pyridine Pyridine,3-bromo-5-(1-methylethoxy) 3-Bromo-5-isopropoxypyridine 3-bromo-5-isopropyloxypyridine |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 241.0±20.0 °C at 760 mmHg |
| Molecular Formula | C8H10BrNO |
| Molecular Weight | 216.075 |
| Flash Point | 99.5±21.8 °C |
| Exact Mass | 214.994568 |
| PSA | 22.12000 |
| LogP | 3.10 |
| Vapour Pressure | 0.1±0.5 mmHg at 25°C |
| Index of Refraction | 1.526 |
| HS Code | 2933399090 |
|---|
|
~58%
212332-40-6 |
| Literature: TARGACEPT, INC. Patent: WO2006/53039 A2, 2006 ; Location in patent: Page/Page column 42 ; |
|
~90%
212332-40-6 |
| Literature: Lucas, Simon; Negri, Matthias; Heim, Ralf; Zimmer, Christina; Hartmann, Rolf W. Journal of Medicinal Chemistry, 2011 , vol. 54, # 7 p. 2307 - 2319 |
|
~%
212332-40-6 |
| Literature: NOVARTIS AG; FURET, Pascal; IMBACH, Patricia; MAH, Robert; STAUFFER, Frederic Patent: WO2010/139747 A1, 2010 ; Location in patent: Page/Page column 210 ; WO 2010/139747 A1 |
|
~32%
212332-40-6 |
| Literature: Bencherif; Merouane; Lippiello; Patrick Michael Patent: US5811442 A1, 1998 ; |
|
~%
212332-40-6 |
| Literature: Leblanc, Catherine; Pulz, Robert Alexander; Stiefl, Nikolaus Johannes Patent: US2009/181941 A1, 2009 ; Location in patent: Page/Page column 49 ; |
|
~88%
212332-40-6 |
| Literature: Bunnelle, William H.; Tietje, Karin R.; Frost, Jennifer M.; Peters, Dan; Ji, Anguo; Li, Tao; Scanio, Marc J. C.; Shi, Lei; Anderson, David J.; Dyhring, Tino; Gronlien, Jens H.; Ween, Hilde; Thorin-Hagene, Kirsten; Meyer, Michael D. Journal of Medicinal Chemistry, 2009 , vol. 52, # 14 p. 4126 - 4141 |
|
~72%
212332-40-6 |
| Literature: Breining, Scott R.; Melvin, Matt; Bhatti, Balwinder S.; Byrd, Gary D.; Kiser, Melanie N.; Hepler, Christopher D.; Hooker, Dawn N.; Zhang, Jenny; Reynolds, Leslie A.; Benson, Lisa R.; Fedorov, Nikolai B.; Sidach, Serguei S.; Mitchener, J. Pike; Lucero, Linda M.; Lukas, Ronald J.; Whiteaker, Paul; Yohannes, Daniel Journal of Medicinal Chemistry, 2012 , vol. 55, # 22 p. 9929 - 9945 |
|
~%
212332-40-6 |
| Literature: Caldwell, William S.; Dull, Gary M.; Bhatti, Balwinder S.; Hadimani, Srishailkumar B.; Park, Haeil; Wagner, Jared M.; Crooks, Peter A.; Lippiello, Patrick M.; Bencherif, Merouane Patent: US2003/125345 A1, 2003 ; |
|
~%
212332-40-6 |
| Literature: Koren, Andrei O.; Horti, Andrew G.; Mukhin, Alexey G.; Guendisch, Daniela; Kimes, Alane S.; Dannals, Robert F.; London, Edythe D. Journal of Medicinal Chemistry, 1998 , vol. 41, # 19 p. 3690 - 3698 |
| Precursor 9 | |
|---|---|
| DownStream 7 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |